Substrate interaction inhibits γ-secretase production of amyloid-β peptides Research Letter


Authors: Zhao, J.; Xiao, Y.; Liu, X.; Kim, S.; Wu, X.; Barros, M.; Zhuang, R.; Hou, X.; Zhang, Y.; Robakis, N. K.; Li, Y. M.; Dordick, J. S.; Ubarretxena-Belandia, I.; Wang, C.
Title: Substrate interaction inhibits γ-secretase production of amyloid-β peptides
Abstract: Combining NMR, mass spectrometry, AlphaLISA and cell assays, we discovered a compound C1 that binds C-terminal juxtamembrane lysines at the transmembrane domain of the amyloid precursor protein (APPTM) and inhibits γ-secretase production of amyloid-β with μM IC50. Our work suggests that targeting APPTM is a novel and viable strategy in AD drug discovery. This journal is © The Royal Society of Chemistry.
Keywords: controlled study; unclassified drug; human cell; drug targeting; mass spectrometry; protein analysis; enzyme inhibition; carboxy terminal sequence; protein interaction; drug structure; cell assay; drug research; nuclear magnetic resonance spectroscopy; enzyme specificity; drug protein binding; alzheimer disease; amyloid precursor protein; gamma secretase; amyloid beta protein[1-40]; amyloid beta protein[1-42]; human; article; ic50; concentration (parameter); compound c1; nootropic agent
Journal Title: Chemical Communications
Volume: 56
Issue: 17
ISSN: 1359-7345
Publisher: Royal Society of Chemistry  
Date Published: 2020-02-28
Start Page: 2578
End Page: 2581
Language: English
DOI: 10.1039/c9cc09170j
PUBMED: 32016207
PROVIDER: scopus
PMCID: PMC8219260
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Xianzhong Wu
    10 Wu
  2. Yueming Li
    132 Li